Mind-body therapies like meditation, psychotherapy, and deep breathing may help reduce stress levels, potentially reducing ...

Patients with chronic spontaneous urticaria experienced substantial reductions in hives and itch with briquilimab through 16 ...

We all know those people. The ones who have trouble with the cold. The ones who seem surprised it’s cold every winter, but who still choose to live in Northeast Ohio.

P39 Compared With Reference Omalizumab in Chronic Spontaneous Urticaria: Results From a Double-Blind, Randomized, ...

Analyst Silvan Tuerkcan of JMP Securities reiterated a Buy rating on Allakos (ALLK – Research Report), with a price target of $3.00.Stay Ahead ...

Rapid onset of deep and durable clinical responses observed across multiple dosing cohorts with a favorable safety profile ...

Management of urticaria de pends on its cause ... for its antithrombotic properties can usually continue regular treatment. It is also good practice to recommend avoiding codeine and other ...

Having a latex allergy is no fun, but it can be a real challenge for health professionals who have to work with a wide ...

RBC Capital analyst Gregory Renza lowered the firm’s price target on Jasper Therapeutics (JSPR) to $48 from $68 and keeps an Outperform rating ...

Cat allergy symptoms range from mild to severe. While most people experience eye, nose, and respiratory-related symptoms, ...

Omalizumab biosimilar is under clinical development by Mabpharm and currently in Phase III for Chronic Urticaria Or Hives.